BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 12082524)

  • 21. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
    Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteins.
    Hyde RK; Griep AE
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1509-16. PubMed ID: 11980867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
    Aslanian A; Iaquinta PJ; Verona R; Lees JA
    Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
    Pantoja C; Serrano M
    Oncogene; 1999 Sep; 18(35):4974-82. PubMed ID: 10490832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
    Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proliferative and apoptotic activities of E2F1 in the mouse retina.
    Lin SC; Skapek SX; Papermaster DS; Hankin M; Lee EY
    Oncogene; 2001 Oct; 20(48):7073-84. PubMed ID: 11704831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
    Hemmati PG; Normand G; Verdoodt B; von Haefen C; Hasenjäger A; Güner D; Wendt J; Dörken B; Daniel PT
    Oncogene; 2005 Jun; 24(25):4114-28. PubMed ID: 15750619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
    Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
    Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
    Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
    Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
    Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.
    Suzuki H; Kurita M; Mizumoto K; Moriyama M; Aiso S; Nishimoto I; Matsuoka M
    Biochem Biophys Res Commun; 2005 Jan; 326(1):242-8. PubMed ID: 15567177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity in the activation and control of transcription factor E2F-dependent apoptosis.
    Hallstrom TC; Nevins JR
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10848-53. PubMed ID: 12954980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence.
    Barradas M; Gonos ES; Zebedee Z; Kolettas E; Petropoulou C; Delgado MD; León J; Hara E; Serrano M
    Exp Cell Res; 2002 Feb; 273(2):127-37. PubMed ID: 11822868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.
    Deneen B; Denny CT
    Oncogene; 2001 Oct; 20(46):6731-41. PubMed ID: 11709708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
    Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
    EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene.
    Ameyar-Zazoua M; Wisniewska MB; Bakiri L; Wagner EF; Yaniv M; Weitzman JB
    Oncogene; 2005 Mar; 24(14):2298-306. PubMed ID: 15688012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.